Imprimis Pharmaceuticals Inc.

Imprimis Pharmaceuticals, Inc. (Imprimis) is a pharmaceutical company. The Company focuses on developing and commercializing compounded drug therapies and making these therapies available to physicians and patients. It owns, markets and sells a portfolio of combination formulations in ophthalmology and urology. Its ophthalmology formulation portfolio includes Dropless Therapy and LessDrops formulations, which serve the eye drop market. Its Defeat IC campaign includes a compounded formulation for patients suffering from interstitial cystitis. It makes, dispenses and sells its compounded formulations, as well as other non-proprietary products, through its compounding pharmacies Pharmacy Creations, LLC (Pharmacy Creations) and Park. Its pharmacies also dispense prescriptions for complementary compounded formulations within the ophthalmology and urology therapeutic areas, as well as other compounded formulations in other therapeutic areas for an individually identified patient.